Belrose Pharma Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development of new treatments for orphan diseases and other conditions with high unmet medical needs. Belrose Pharma currently has two Phase 2/3 clinical programs and two additional earlier stage candidates with the potential for accelerated approval based on an abbreviated approval pathway.
Belrose has assembled a world-class management team and Advisory Board. Each member of our management team draws on their experience to help advance Belrose’s clinical programs.
Belrose is deploying its proprietary “releasable linker” conjugation technology and other techniques to improve the clinical efficacy of both novel therapeutics and approved molecules that would benefit from improved PK profile, increased bioavailability and more convenient administration.
Company Details
- Employees
- 12
- Address
- 3000 Eastpark Blvd, Cranbury,new Jersey 08512,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- St Leonards.
- HQ
- Cranbury, New Jersey
Belrose Pharma Inc. Questions
Belrose Pharma Inc.'s website is https://www.belrosepharmainc.com/
Belrose Pharma Inc.'s LinkedIn profile is https://www.linkedin.com/company/belrose-pharma-inc
Belrose Pharma Inc. has
12 employees.
View email and phone details for 12
employees at Belrose Pharma Inc..
Belrose Pharma Inc.'s industry is
Biotechnology Research
Belrose Pharma Inc.'s top competitors are
Gylden Pharma,
Tharimmune, Inc.,
Brainstorm Cell Therapeutics,
Aprea Therapeutics,
Herbist Nutrition Company,
Evrys Bio,
Kolling Institute,
Pennsylvania Biotechnology Center.
Belrose Pharma Inc.'s categories are Biotechnology Research
